InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,620.85
(
0.42%
)
US TECH 100
19,332.00
(
0.63%
)
Dow Jones
40,890.49
(
0.14%
)
Brent Oil
75.36
(
-0.44%
)
Bitcoin
60,911.69
(
3.23%
)

Replies to post #152778 on Biotech Values

Replies to #152778 on Biotech Values
icon url

mcbio

11/20/12 3:35 PM

#152780 RE: DewDiligence #152778

There was a phase-2 trial in Behçet’s uveitis.

Found it: http://investors.xoma.com/releasedetail.cfm?ReleaseID=528942 . Any comments on the market size here? Wonder what projections are in this indication and can't recall off-hand the economics of the Servier deal.
icon url

BTH

11/20/12 4:06 PM

#152784 RE: DewDiligence #152778

XOMA ANNOUNCES PERINDOPRIL AND AMLODIPINE FIXED-DOSE COMBINATION MEETS PRIMARY ENDPOINT IN PHASE 3 PATH TRIAL